• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对肢端肥大症患者进行生长激素释放因子(GHRF)测试以评估治疗效果。

GHRF test in acromegalic patients for the evaluation of therapeutic results.

作者信息

Hanew K, Sato S, Sasaki A, Goh M, Shimizu Y, Murakami O, Yoshinaga K

出版信息

Tohoku J Exp Med. 1985 Nov;147(3):273-80. doi: 10.1620/tjem.147.273.

DOI:10.1620/tjem.147.273
PMID:3937295
Abstract

We studied here the clinical significance of GHRF test in evaluating therapeutic results in patients with acromegaly. Three cases of acromegaly were studied at pre- and posttreatment. Case 1 is a 42 year old woman, and her plasma GH showed slight increases responding to TRH and arginine administration before therapy. Eleven years after the pituitary irradiation, basal plasma GH decreased to low normal ranges and showed no response to the above two agents. Only an insufficient increase in plasma GH was observed after GHRF injection. This case would have pituitary lesions not only in the tumor somatotrophs but also in the normal somatotrophs. Case 2 is a 38 year old man. His plasma GH showed a marked increase after TRH injection. To GHRF administration, however, no clear response was observed. After transsphenoidal adenomectomy, the aberrant responses to TRH was still observed despite the marked GH decrease to the near normal ranges. Interestingly, plasma GH became responsive to GHRF after the operation. It seems that the adenomectomy was inadequate in this case and the normal somatotrophs recovered the responsiveness to GHRF. Case 3 is a 53 year old woman, and she showed aberrant GH responses to TRH and to L-dopa. Her plasma GH clearly increased after GHRF injection. Postoperatively, the abnormal responses of plasma GH disappeared completely, while a normal GH response was observed following GHRF injection.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们在此研究了生长激素释放因子(GHRF)试验在评估肢端肥大症患者治疗效果中的临床意义。对3例肢端肥大症患者在治疗前和治疗后进行了研究。病例1为一名42岁女性,治疗前其血浆生长激素(GH)对促甲状腺激素释放激素(TRH)和精氨酸给药有轻微升高反应。垂体放疗11年后,基础血浆GH降至低正常范围,对上述两种药物无反应。注射GHRF后仅观察到血浆GH升高不足。该病例的垂体病变不仅存在于肿瘤生长激素细胞中,也存在于正常生长激素细胞中。病例2为一名38岁男性。注射TRH后其血浆GH显著升高。然而,给予GHRF后未观察到明显反应。经蝶窦腺瘤切除术后,尽管GH显著下降至接近正常范围,但对TRH的异常反应仍存在。有趣的是,术后血浆GH对GHRF有反应。似乎该病例的腺瘤切除术不彻底,正常生长激素细胞恢复了对GHRF的反应性。病例3为一名53岁女性,她对TRH和左旋多巴表现出异常的GH反应。注射GHRF后其血浆GH明显升高。术后,血浆GH的异常反应完全消失,而注射GHRF后观察到正常的GH反应。(摘要截短于250字)

相似文献

1
GHRF test in acromegalic patients for the evaluation of therapeutic results.对肢端肥大症患者进行生长激素释放因子(GHRF)测试以评估治疗效果。
Tohoku J Exp Med. 1985 Nov;147(3):273-80. doi: 10.1620/tjem.147.273.
2
Comparative study on the responses of plasma GH to synthetic GH-releasing factor and other stimulatory and inhibitory agents in patients with acromegaly.
Tohoku J Exp Med. 1985 Feb;145(2):161-6. doi: 10.1620/tjem.145.161.
3
Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.肢端肥大症中垂体激素对下丘脑释放激素的反应。
Acta Endocrinol (Copenh). 1976 Dec;83(4):673-83. doi: 10.1530/acta.0.0830673.
4
Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
Tohoku J Exp Med. 1977 Mar;121(3):197-206. doi: 10.1620/tjem.121.197.
5
Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.生长激素细胞增生。通过切除分泌生长激素释放因子的胰岛肿瘤成功治疗肢端肥大症。
J Clin Invest. 1982 Nov;70(5):965-77. doi: 10.1172/jci110708.
6
[Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].[肢端肥大症中I-多巴试验的重新评估:解剖临床及预后相关性]
Minerva Chir. 1993 Nov;48(21-22):1337-40.
7
Calcium signalling in single growth hormone-releasing factor-responsive pituitary cells.
Endocrinology. 1992 Feb;130(2):945-53. doi: 10.1210/endo.130.2.1733736.
8
Secretion of growth hormone-releasing hormone in patients with idiopathic pituitary dwarfism and acromegaly.特发性垂体性侏儒症和肢端肥大症患者生长激素释放激素的分泌。
Acta Endocrinol (Copenh). 1988 Mar;117(3):273-81. doi: 10.1530/acta.0.1170273.
9
Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.肢端肥大症患者生长激素(GH)分泌对生长激素释放激素、促甲状腺激素释放激素、促性腺激素释放激素及生长抑素反应的研究。
J Clin Endocrinol Metab. 1986 Jul;63(1):167-73. doi: 10.1210/jcem-63-1-167.
10
Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.促肾上腺皮质激素释放激素给药对肢端肥大症患者生长激素水平的影响:体内和体外研究
Eur J Endocrinol. 1994 Jul;131(1):14-9. doi: 10.1530/eje.0.1310014.